Traws Pharma, Inc. · NASDAQ:TRAW
Ikarian Capital, LLC reported a 9.50% stake in Traws Pharma, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Ikarian Capital, LLC reported a 9.50% stake in Traws Pharma, Inc., 1,555,423 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.50%
- Shares
- 1,555,423
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ikarian Capital, LLC | 9.50% | 1,555,423 |
| Neil Shahrestani | 9.50% | 1,555,423 |
Source
Related
- Traws Pharma, Inc.
- Ikarian Capital, LLC
- Traws Pharma, Inc. shareholders
- Schedule 13G/A · Ikarian Capital, LLC · Feb 17, 2026
- Schedule 13G/A · Ikarian Capital, LLC · May 15, 2025
- Schedule 13G · Ikarian Capital, LLC · Feb 14, 2025
- Schedule 13G · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13G/A · Squadron Capital Management LLC · May 15, 2026